Perceptions of genetic discrimination among people at risk for Huntington’s disease: a cross sectional survey

Objective To assess the nature and prevalence of genetic discrimination experienced by people at risk for Huntington’s disease who had undergone genetic testing or remained untested. Design Cross sectional, self reported survey. Setting Seven genetics and movement disorders clinics servicing rural and urban communities in Canada. Participants 233 genetically tested and untested asymptomatic people at risk for Huntington’s disease (response rate 80%): 167 underwent testing (83 had the Huntington’s disease mutation, 84 did not) and 66 chose not to be tested. Main outcome measures Self reported experiences of genetic discrimination and related psychological distress based on family history or genetic test results. Results Discrimination was reported by 93 respondents (39.9%). Reported experiences occurred most often in insurance (29.2%), family (15.5%), and social (12.4%) settings. There were few reports of discrimination in employment (6.9%), health care (8.6%), or public sector settings (3.9%). Although respondents who were aware that they carried the Huntington’s disease mutation reported the highest levels of discrimination, participation in genetic testing was not associated with increased levels of genetic discrimination. Family history of Huntington’s disease, rather than the result of genetic testing, was the main reason given for experiences of genetic discrimination. Psychological distress was associated with genetic discrimination (P<0.001). Conclusions Genetic discrimination was commonly reported by people at risk for Huntington’s disease and was a source of psychological distress. Family history, and not genetic testing, was the major reason for genetic discrimination.

[1]  M. Hayden.  Predictive testing for Huntington's disease: a universal model? , 2003, The Lancet Neurology.

[2]  M. Friedrich.  Preserving privacy, preventing discrimination becomes the province of genetics experts. , 2002, JAMA.

[3]  N. Krieger.  Embodying Inequality: A Review of Concepts, Measures, and Methods for Studying Health Consequences of Discrimination , 1999, International journal of health services : planning, administration, evaluation.

[4]  P. Moszynski.  New commission on HIV/AIDS and governance in Africa is launched , 2003, BMJ : British Medical Journal.

[5]  D Curran-Everett,et al.  Multiple comparisons: philosophies and illustrations. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  Y. Bombard,et al.  Genetic testing and Huntington's disease: issues of employment , 2004, The Lancet Neurology.

[7]  Jane S. Paulsen,et al.  Managing genetic discrimination: Strategies used by individuals found to have the Huntington disease mutation , 2007, Clinical genetics.

[8]  Joseph B. Martin.  Huntington's disease , 1984, Neurology.

[9]  J. Tanne.  US Senate outlaws genetic discrimination , 2008, BMJ : British Medical Journal.

[10]  M. Hayden,et al.  Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene: Relevance for Other Adult-Onset Disorders , 1993 .

[11]  A. Durr,et al.  Presymptomatic testing in Huntington’s disease and autosomal dominant cerebellar ataxias , 2002, Neurology.

[12]  N. Krieger,et al.  Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. , 2005, Social science & medicine.

[13]  S. Kessler.  Predictive testing for Huntington disease: a psychologist's view. , 1994, American journal of medical genetics.

[14]  A. Orr,et al.  Huntington's chorea , 1969, Journal of neurochemistry.

[15]  S. Sheps,et al.  The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. , 1993, The New England journal of medicine.

[16]  David R. Williams,et al.  Self-reported racial discrimination and substance use in the Coronary Artery Risk Development in Adults Study. , 2007, American journal of epidemiology.

[17]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[18]  D. Craufurd,et al.  Ethics of predictive testing for Huntington's chorea: the need for more information. , 1986, British medical journal.

[19]  P. Morrison.  Insurance, unfair discrimination, and genetic testing , 2005, The Lancet.

[20]  H. Greely.  Banning genetic discrimination. , 2005, The New England journal of medicine.

[21]  N. Krieger,et al.  Racial discrimination and skin color in the CARDIA study: implications for public health research. Coronary Artery Risk Development in Young Adults. , 1998, American journal of public health.

[22]  G. Evers‐Kiebooms,et al.  The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education. , 2000, Social science & medicine.

[23]  S. Steinberg,et al.  Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. , 2003, Archives of internal medicine.

[24]  P. Moszynski.  Campaigners draw attention to disfiguring childhood disease , 2008, BMJ : British Medical Journal.

[25]  M R Natowicz,et al.  Discrimination as a consequence of genetic testing. , 1992, American journal of human genetics.

[26]  Sandi Wiggins,et al.  The Psychological Consequences of Predictive Testing for Huntington’s Disease , 1992 .

[27]  J. Brandt,et al.  Psychological costs and benefits of predictive testing for Huntington's disease. , 1994, American journal of medical genetics.

[28]  C. Kozma,et al.  Genetic Discrimination: Perspectives of Consumers , 1996, Science.

[29]  S. Youngman,et al.  EXCLUSION TESTING FOR HUNTINGTON'S DISEASE IN PREGNANCY WITH A CLOSELY LINKED DNA MARKER , 1987, The Lancet.

[30]  R. Roos,et al.  Unified Huntington's disease rating scale: A follow up , 1998, Movement disorders : official journal of the Movement Disorder Society.

[31]  David R. Williams,et al.  The prevalence, distribution, and mental health correlates of perceived discrimination in the United States. , 1999, Journal of health and social behavior.

[32]  T. Wilkie,et al.  Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom , 1998, BMJ.

[33]  T. Perry.  Some ethical problems in Huntington's chorea. , 1981, Canadian Medical Association journal.

[34]  M. Hayden,et al.  FIRST-TRIMESTER PRENATAL DIAGNOSIS FOR HUNTINGTON'S DISEASE WITH DNA PROBES , 1987, The Lancet.

[35]  Shirley Hansen,et al.  Huntington's Chorea , 1973 .

[36]  B. Bernhardt,et al.  Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients , 2004, Genetics in medicine : official journal of the American College of Medical Genetics.

[37]  S. Mayor.  Report warns of danger of genetic discrimination in the workplace , 2003, BMJ : British Medical Journal.

[38]  G. Mudur.  Proposals to strengthen ban on prenatal sex determination hide inaction, activists claim , 2008, BMJ : British Medical Journal.

[39]  P. Chisnall.  Mail and Internet Surveys: The Tailored Design Method , 2007, Journal of Advertising Research.

[40]  E. Thomson,et al.  Concerns in a primary care population about genetic discrimination by insurers , 2005, Genetics in Medicine.

[41]  S. Sobel,et al.  Impact of genetic testing for Huntington disease on the family system. , 2000, American journal of medical genetics.

[42]  S. Merajver,et al.  Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  M. Morris,et al.  Reluctance to undergo predictive testing: the case of Huntington disease. , 1993, American journal of medical genetics.

[44]  Jane S. Paulsen,et al.  Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease , 2008, European Journal of Human Genetics.

[45]  M. Hayden,et al.  Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. , 1993, JAMA.

[46]  G. Watts.  The quality enforcer , 2003, BMJ : British Medical Journal.

[47]  S. Treloar,et al.  Investigating genetic discrimination in Australia: a large‐scale survey of clinical genetics clients , 2008, Clinical genetics.